What Nucleic Acid Therapeutics specifies
These figures apply to every manuscript type at Nucleic Acid Therapeutics. Review proposed changes and verify the final manuscript against the official author guidance.
- All manuscript types 5 recorded requirements
Read from Nucleic Acid Therapeutics's own author guidelines. Journals revise these. Verify with the journal before you submit.
About Nucleic Acid Therapeutics
- Publisher
- Mary Ann Liebert, Inc.
- ISSN
- 2159-3337, 2159-3345
- Abbreviation
- Nucleic Acid Ther
- h-index
- 63
- Citations
- 18,834
- Articles indexed
- 638
Citation figures from OpenAlex.
Preparing a submission for Nucleic Acid Therapeutics
Scraiber has 5 requirements on file for Nucleic Acid Therapeutics, covering areas such as length, references, structure and submission policies. The journal’s official guidance remains the reference for your submission.
Select Nucleic Acid Therapeutics and your manuscript type, then upload your draft to preview proposed text changes. Review the suggestions before applying them.
Retargeting a manuscript to Nucleic Acid Therapeutics may require changes to length, structure, references and declarations. Scraiber suggests revisions to your existing draft; authors must check the scientific meaning and supply any missing factual declarations.
Changes to review in your manuscript
Scraiber proposes text revisions informed by Nucleic Acid Therapeutics’s recorded requirements. Check each change for scientific meaning, references and missing declarations. Authors remain responsible for the final manuscript.
Frequently asked questions
- How do I check my manuscript against the Nucleic Acid Therapeutics guidelines?
- Choose your manuscript type and follow the preview button to upload a .docx for Nucleic Acid Therapeutics. Review the proposed changes before you apply any of them.
- What are the submission requirements for Nucleic Acid Therapeutics?
- Scraiber has 5 requirements on file for Nucleic Acid Therapeutics. Choose your manuscript type to see recorded limits and consult the linked official guidance for the current submission requirements.
- Which citation style does Nucleic Acid Therapeutics use?
- Consult Nucleic Acid Therapeutics’s official guidance for its citation style. Scraiber can suggest revisions using the recorded requirements; check citations and the bibliography before submission.
- Can I automatically format my paper for Nucleic Acid Therapeutics?
- Upload your draft and select Nucleic Acid Therapeutics and your manuscript type. Scraiber proposes text changes for review. Check the final manuscript against the official guidance; the preview does not guarantee complete compliance or acceptance.
- How do I reformat a paper rejected by another journal for Nucleic Acid Therapeutics?
- Select Nucleic Acid Therapeutics and the manuscript type, then upload your existing draft. Review the proposed revisions and check references, declarations and scientific meaning before submission.
- How long does it take to prepare a manuscript for Nucleic Acid Therapeutics?
- Preparation time depends on your draft, the journal’s requirements and the author review needed. A preview lets you inspect proposed changes before deciding to continue.
- Do I have to redo my references for Nucleic Acid Therapeutics?
- Review your citations and bibliography against Nucleic Acid Therapeutics’s current guidance. Suggested text changes do not replace checking the accuracy, completeness and style of your references.
- Who publishes Nucleic Acid Therapeutics?
- Nucleic Acid Therapeutics is published by Mary Ann Liebert, Inc..
- What is the ISSN of Nucleic Acid Therapeutics?
- Nucleic Acid Therapeutics is listed under the ISSNs 2159-3337, 2159-3345.
- What is the abbreviation of Nucleic Acid Therapeutics?
- Nucleic Acid Therapeutics is abbreviated as Nucleic Acid Ther.
Official author guidelines: liebertpub.com
